Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC50 of liposomal bupivacaine for supra-inguinal fascia iliaca block in elderly THA
ChiCTR2500112398Phase 4Recruiting
- Sponsor
- Luxian People's Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupivacaine in hip osteoarthritis, sponsored by Luxian People's Hospital. Primary endpoints: EC50 of liposomal bupivacaine for S-FICB and Muscle Strength Grading (MRC). Started Nov 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on ChiCTR2500112398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112398.